NCT03642847 - Trial to Evaluate the Safety and Immunogenicity of Multivalent Pneumococcal Vaccines in Japanese Adults 18 to 49 Years of Age | Biotech Hunter

Enrollment

104

Participants

Timeline

Start Date

August 29, 2018

Primary Completion Date

March 29, 2019

Study Completion Date

March 29, 2019

Conditions

Pneumococcal Infections

Interventions

BIOLOGICAL

Prevnar 13

13 valent Pneumococcal Conjugate

BIOLOGICAL

multivalent pneumococcal conjugate formulation 1

BIOLOGICAL

multivalent pneumococcal conjugate formulation 2

Trial Locations (4)

Collaborative Neuroscience Network, LLC., Long Beach

Collaborative Neuroscience Network, LLC., Garden Grove

East-West Medical Research Institute, Honolulu

Clinilabs Drug Development Corporation, Eatontown